Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiaolin Deng

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Cell Reports. Medicine|April 23, 2025
CD47-blocking antibody confers metabolic benefits against obesityYajuan Su, Jingyu Sun, Xiaobo Li, et al.
Nature Communications|July 16, 2022
ZnT8 loss-of-function accelerates functional maturation of hESC-derived β cells and resists metabolic stress in diabetesQing Ma, Yini Xiao, Wenjun Xu, et al.
Annals of the Rheumatic Diseases|February 9, 2025
Characterisation of the antinociceptive effect of baricitinib in the collagen antibody-induced arthritis mouse modelNils Simon, Resti Rudjito, Lydia Moll, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 27, 2019
Intussusceptive Vascular Remodeling Precedes Pathological NeovascularizationZaheer Ali, Anthony Mukwaya, Antje Biesemeier, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2011
SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitorsZhijian Lu, Yi-Heng Chen, Joann B Napolitano, et al.
Journal of Medicinal Chemistry|March 25, 2009
Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in ratsHong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.
Cell Reports. Medicine|November 12, 2025
Maternal diabetes programs sexually dimorphic early-onset cardiovascular dysfunction in metabolically healthy offspringAllan Zhao, Yuxia Wei, Eftychia Kontidou, et al.
Journal of Medicinal Chemistry|May 14, 2025
Discovery and Characterization of PVTX-321 as a Potent and Orally Bioavailable Estrogen Receptor Degrader for ER+/HER2- Breast CancerGuozhang Xu, Courtney G Havens, Qiaolin Deng, et al.
Journal of Medicinal Chemistry|August 4, 2009
Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagementHong C Shen, Fa-Xiang Ding, Siyi Wang, et al.
Journal of Medicinal Chemistry|November 13, 2007
Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptorHong C Shen, Fa-Xiang Ding, Silvi Luell, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Cell Reports. Medicine|April 23, 2025
CD47-blocking antibody confers metabolic benefits against obesityYajuan Su, Jingyu Sun, Xiaobo Li, et al.
Nature Communications|July 16, 2022
ZnT8 loss-of-function accelerates functional maturation of hESC-derived β cells and resists metabolic stress in diabetesQing Ma, Yini Xiao, Wenjun Xu, et al.
Annals of the Rheumatic Diseases|February 9, 2025
Characterisation of the antinociceptive effect of baricitinib in the collagen antibody-induced arthritis mouse modelNils Simon, Resti Rudjito, Lydia Moll, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 27, 2019
Intussusceptive Vascular Remodeling Precedes Pathological NeovascularizationZaheer Ali, Anthony Mukwaya, Antje Biesemeier, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2011
SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitorsZhijian Lu, Yi-Heng Chen, Joann B Napolitano, et al.
Journal of Medicinal Chemistry|March 25, 2009
Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in ratsHong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.
Cell Reports. Medicine|November 12, 2025
Maternal diabetes programs sexually dimorphic early-onset cardiovascular dysfunction in metabolically healthy offspringAllan Zhao, Yuxia Wei, Eftychia Kontidou, et al.
Journal of Medicinal Chemistry|May 14, 2025
Discovery and Characterization of PVTX-321 as a Potent and Orally Bioavailable Estrogen Receptor Degrader for ER+/HER2- Breast CancerGuozhang Xu, Courtney G Havens, Qiaolin Deng, et al.
Journal of Medicinal Chemistry|August 4, 2009
Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagementHong C Shen, Fa-Xiang Ding, Siyi Wang, et al.
Journal of Medicinal Chemistry|November 13, 2007
Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptorHong C Shen, Fa-Xiang Ding, Silvi Luell, et al.
Pageof 10